The company responsible for processing your personal data is:

Novo Nordisk Panama S.A.
Torre MMG, 11th floor , Avenida Paseo del Mar, Costa del Este, Corregimiento de Juan Díaz, Panama City, Republic of Panama
Company register number: 155621514-2-2016 DV 2
Email: CONTACTOCLAT@novonordisk.com
Phone: +507 833-9262

You can always contact Novo Nordisk Panama S.A. or the Novo Nordisk Data Privacy Officer at contactoclat@novonordisk.com  with questions or concerns about how we process your personal data.

We get your personal data from the following sources:

• From you directly
• From your family members or care givers on your behalf
• From Health Care Professionals such as your nurse, a pharmacist or doctor
• Through phone calls, emails and other digital channels

We process personal data about you for the following purposes

• To perform scientific evaluations of complaints and side effects potentially related to Novo Nordisk’s medicinal products. Complaints and side effects will be filed in databases and will be regularly analysed for overall patterns.
• To respond to your questions or request for information
• To analyse data for the purpose of supporting product usage enquiries
• To analyse data for the purpose of improving our customer service and product offerings
• To analyse data for the purpose of improve our scientific and product communication to HCPs and patients 
• To assess patterns and trends associated with complaints, side effect and product usage

For the purposes described above in Section 3, we may process the following types of personal data:

• Contact information (name, address, telephone number, email address);
• Data revealing racial or ethnic origin;
• Data concerning health and medicinal products you are using;

Our processing of your personal data requires a legal basis. By law, we are allowed to process your personal data described above in Section 4 based on the following legal bases:

• The processing is necessary for our legitimate interests. The legitimate interests are:

a. The processing is necessary for our compliance with a legal obligation

b. To perform scientific evaluations of complaints and side effects potentially related to Novo Nordisk’s medicinal products.

c. To improve our customer service and product offerings

d. To enhance our scientific and product communication

e. You gave consent for us to process your personal data

We may share your personal data with:

• Suppliers or vendors that assist our company (e.g., consultants, IT service providers, financial institutions, law firms, license partners)
• Other Novo Nordisk entities (e.g., Novo Nordisk affiliates in other countries)
• Public authorities, including health and/or regulatory authorities
• Other pharma companies and partners if an enquiry is related to their product(s)

We will keep your personal data for the following period of time:

• For data relating to technical complaints: 12 years
• For safety information and data relating to side effects: End of activity + 10 years, where end of activity is the time where no product with the active ingredient is marketed
• For all other enquiries: Up to 5 years

In general, you have the following rights:

Under applicable law, there may be limits on these rights depending on the specific circumstances of the processing activity. Contact us as described in Section 1 with questions or requests relating to these rights.